Point-of-care CD4 testing: Differentiated care for the most vulnerable.

J Glob Health · 2022 · PMC8818294 · PMID 35136596

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

ART initiation and time to treat The primary end point analysis revealed that of all the participants eligible for ART (n = 406), 73% in the POC PIMA and 68% in the SOC Central laboratory group, initiated ART within 3 months/90 days, although this difference did not reach statistical significance.

also in 111,027 other papers

borderline significanceno p-value reported

This however denotes only borderline significance due to the small sample number in this group.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.